Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker BOLT
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 12, 2026 | BOLT Bolt Biotherapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 23, 2026 | BOLT Bolt Biotherapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 23, 2026 | BOLT Bolt Biotherapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 23, 2026 | BOLT Bolt Biotherapeutics, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Oct 23, 2026 | BOLT Bolt Biotherapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 23, 2026 | BOLT Bolt Biotherapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Oct 23, 2026 | BOLT Bolt Biotherapeutics, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Oct 23, 2026 | BOLT Bolt Biotherapeutics, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 23, 2026 | BOLT Bolt Biotherapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 6, 2026 | BOLT Bolt Biotherapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 11, 2026 | BOLT Bolt Biotherapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 11, 2026 | BOLT Bolt Biotherapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 12, 2026 | BOLT Bolt Biotherapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 12, 2026 | BOLT Bolt Biotherapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 2, 2025 | BOLT Bolt Biotherapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 2, 2025 | BOLT Bolt Biotherapeutics, Inc. | 2.05 Costs Associated with Exit or Disposal Activities | 8-K | 8-K ↗ |
| Aug 14, 2025 | BOLT Bolt Biotherapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 6, 2025 | BOLT Bolt Biotherapeutics, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Jun 6, 2025 | BOLT Bolt Biotherapeutics, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Jun 4, 2025 | BOLT Bolt Biotherapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 28, 2025 | BOLT Bolt Biotherapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 16, 2025 | BOLT Bolt Biotherapeutics, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Mar 24, 2025 | BOLT Bolt Biotherapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 3, 2025 | BOLT Bolt Biotherapeutics, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Dec 23, 2024 | BOLT Bolt Biotherapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 12, 2024 | BOLT Bolt Biotherapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
28 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:51 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances